Product image of Yaxwer (Denosumab) supplied by GNH India

Yaxwer

Active Ingredient:
Denosumab
Origin:
EU

Yaxwer (Denosumab)

Yaxwer (Denosumab) is a prescription medication used to treat bone loss and osteoporosis in adults. It helps strengthen bones and reduce fracture risk by slowing bone breakdown. This subcutaneous injection is prescribed for postmenopausal women and men at high risk of fractures.

Manufacturer / TM Owner

Gedeon Richter Plc.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Indications & Clinical Uses

  • Denosumab is commonly prescribed to treat osteoporosis in postmenopausal women and men who are at high risk of bone fractures. It is also used to increase bone mass in patients receiving certain cancer treatments that can weaken bones. The medication works by targeting cells that break down bone tissue, helping to maintain bone strength over time.

Side Effects

  • After administration, Denosumab helps slow the natural process of bone breakdown, which can lead to improved bone density. Patients may notice gradual improvements in mobility and comfort as bone strength increases. Regular use is often associated with reduced risk of fractures and better overall bone health.

Precautions & Warnings

  • Yaxwer should be handled with care, and injections are typically administered by a healthcare professional. Patients with low calcium levels should have this condition treated before starting Denosumab. Regular dental check-ups are recommended, as rare cases of jaw problems have been reported with long-term use.

Avoid Interactions

  • Denosumab may interact with medications that affect bone metabolism, such as corticosteroids or certain cancer treatments. Combining it with other bone-strengthening drugs should be done under medical supervision. Patients should inform their doctor about all medications, including over-the-counter and herbal products, before starting treatment.

Frequently Asked Questions

Yaxwer is used to treat osteoporosis in postmenopausal women and men at high risk of fractures.

Denosumab is given as a subcutaneous injection, typically by a healthcare professional every 6 months.

Common side effects may include back pain, joint pain, or muscle aches. Rarely, it may affect calcium levels or bone healing.

Patients with low calcium levels or severe kidney problems should use Denosumab with caution. Pregnant or breastfeeding women should consult a doctor.

Long-term use of Denosumab is generally considered safe under medical supervision, but regular monitoring is recommended.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Denosumab

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT